VALERIE COOPER: Open Payments
NPI 1487624417 · ISSAQUAH, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,335 in 153 payments from 18 companies in 2025. Trend: 2023 $255 · 2024 $1,484 · 2025 $3,335
Food & beverage: $3,255Education: $80
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 20 | $431 |
| ABBVIE INC. | 24 | $419 |
| Incyte Corporation | 13 | $338 |
| Janssen Biotech, Inc. | 14 | $303 |
| Lilly USA, LLC | 9 | $302 |
| GENZYME CORPORATION | 10 | $273 |
| Novartis Pharmaceuticals Corporation | 19 | $268 |
| Galderma Laboratories, L.P. | 8 | $167 |
| LEO Pharma Inc. | 7 | $164 |
| Amgen Inc. | 6 | $142 |
Products named: Zoryve, DUPIXENT, OPZELURA, TREMFYA, COSENTYX, SKYRIZI, TALTZ, NEMLUVIO.
Industry payments across WA — which companies pay providers there.
